Sugammadex in the management of rocuronium-induced anaphylaxis

British Journal of Anaesthesia

Volumn 106, Issue 2, 2011, Pages 199-201

  McDonnell, N J ^a,b,c   Pavy, T J G ^b,c   Green, L K ^c   Platt, P R ^d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c KING EDWARD MEMORIAL HOSPITAL   (Australia)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

anaphylaxis; rocuronium; sugammadex

Indexed keywords

FENTANYL; PROPOFOL; ROCURONIUM; SUGAMMADEX;

ADULT; ANAMNESIS; ANAPHYLAXIS; ANESTHESIA INDUCTION; ARTICLE; CASE REPORT; FEMALE; HEMODYNAMIC PARAMETERS; HUMAN; PRIORITY JOURNAL;

EID: 78751532765     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeq366     Document Type: Article

References (19)

1. Harper NJ, Dixon T, Dugue P, et al. Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia 2009; 64: 199-211
2. Laxenaire MC, Mertes PM. Anaphylaxis during anaesthesia. Results of a two-year survey in France. Br J Anaesth 2001; 87: 549-58
3. Mertes PM, Laxenaire MC. Anaphylactic and anaphylactoid reactions occurring during anaesthesia in France. Seventh epidemiologic survey (January 2001-December 2002). Ann Fr Anesth Reanim 2004; 23: 1133-43
4. Ebo DG, Fisher MM, Hagendorens MM, Bridts CH, Stevens WJ. Anaphylaxis during anaesthesia: diagnostic approach. Allergy 2007; 62: 471-87
5. Fisher MM, Baldo BA. The incidence and clinical features of anaphylactic reactions during anesthesia in Australia. Ann Fr Anesth Reanim 1993; 12: 97-104
6. Hepner DL, Castells MC. Anaphylaxis during the perioperative period. Anesth Analg 2003; 97: 1381-95
7. Scadding GK. Treatment of acute anaphylaxis. Remove the patient from contact with the allergen. Br Med J 1995; 311: 1434
8. Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg 2007; 104: 575-81
9. Jones PM, Turkstra TP. Mitigation of rocuronium-induced anaphylaxis by sugammadex: the great unknown. Anaesthesia 2010; 65: 89-90
10. Rose M, Fisher M. Rocuronium: high risk for anaphylaxis? Br J Anaesth 2001; 86: 678-82
11. Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003; 99: 536-45
12. Axon AD, Hunter JM. Editorial III: Anaphylaxis and anaesthesia- all clear now? Br J Anaesth 2004; 93: 501-4
13. Yang LP, Keam SJ. Sugammadex: a review of its use in anaesthetic practice. Drugs 2009; 69: 919-42
14. Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology 2005; 103: 695-703
15. Jones RK, Caldwell JE, Brull SJ, Soto RG. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology 2008; 109: 816-24
16. McBrien ME,Webb ST, Breslin DS. Anaphylaxis and anaesthesia. Br J Anaesth 2005; 94: 547-8
17. Heytman M, Rainbird A. Use of alpha-agonists for management of anaphylaxis occurring under anaesthesia: case studies and review. Anaesthesia 2004; 59: 1210-5
18. Meng L, Williams EL. Case report: treatment of rocuronium-induced anaphylactic shock with vasopressin. Can J Anaesth 2008; 55: 437-40
19. Schummer C, Wirsing M, Schummer W. The pivotal role of vasopressin in refractory anaphylactic shock. Anesth Analg 2008; 107: 620-4